Patents by Inventor Christopher T. Cordle
Christopher T. Cordle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9844517Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: GrantFiled: January 20, 2015Date of Patent: December 19, 2017Assignee: ABBOTT LABORATORIESInventors: Chron-Si Lai, John B. Lasekan, Gary E. Katz, Christopher T. Cordle
-
Patent number: 9446005Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: GrantFiled: May 9, 2014Date of Patent: September 20, 2016Assignee: Abbott LaboratoriesInventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis, Christopher T. Cordle, Russell J. Merritt
-
Patent number: 9078846Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: GrantFiled: December 21, 2011Date of Patent: July 14, 2015Assignee: ABBOTT LABORATORIESInventors: Chron-Si Lai, John B. Lasekan, Christopher T. Cordle
-
Publication number: 20150132466Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: ApplicationFiled: January 20, 2015Publication date: May 14, 2015Applicant: ABBOTT LABORATORIESInventors: CHRON-SI LAI, JOHN B. LASEKAN, GARY E. KATZ, CHRISTOPHER T. CORDLE
-
Publication number: 20140249224Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: ApplicationFiled: May 9, 2014Publication date: September 4, 2014Applicant: ABBOTT LABORATORIESInventors: CHRON-SI LAI, KEITH A. GARLEB, JOHN B. LASEKAN, STEVEN R. DAVIS, CHRISTOPHER T. CORDLE, RUSSELL J. MERRITT
-
Patent number: 8754126Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: GrantFiled: December 21, 2011Date of Patent: June 17, 2014Assignee: Abbott LaboratoriesInventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis, Christopher T. Cordle, Russell J. Merritt
-
Publication number: 20130243904Abstract: Disclosed are nutritional products comprising pea protein hydrolysates as a primary or sole source of protein. The nutritional products include nutritional liquids, powders, bars, and other food products, wherein the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties. These nutritional products may be used as a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and soy proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.Type: ApplicationFiled: August 22, 2011Publication date: September 19, 2013Applicant: ABBOTT LABORATORIESInventors: Christopher T. Cordle, Steven T. Luebbers, Larry W. Williams, Jeffrey Harris Baxter, Geralyn Duska-Mcewen
-
Publication number: 20120171350Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: ApplicationFiled: December 21, 2011Publication date: July 5, 2012Applicant: ABBOTT LABORATORIESInventors: Chron-Si Lai, John B. Lasekan, Christopher T. Cordle
-
Publication number: 20120172445Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: ApplicationFiled: December 21, 2011Publication date: July 5, 2012Applicant: ABBOTT LABORATORIESInventors: Chron-Si Lai, John B. Lasekan, Gary E. Katz, Christopher T. Cordle
-
Publication number: 20120172434Abstract: Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.Type: ApplicationFiled: December 21, 2011Publication date: July 5, 2012Applicant: ABBOTT LABORATORIESInventors: Chron-Si Lai, Keith A. Garleb, John B. Lasekan, Steven R. Davis, Christopher T. Cordle, Russell J. Merritt
-
Patent number: 6245803Abstract: This invention relates to a palatable elemental nutritional formula that is nutritionally complete for humans with specialized dietary needs. The nutritional of the present invention uses specific free amino acids to provide the source of amino nitrogen (protein equivalents) and a special blend of fats that provides 38 to 50% of the total Calories in a pleasant tasting formula. The nutritionally complete formula of this invention is useful for children having multiple protein allergies, short gut syndrome, sick gut, diarrhea and the like. More specifically, the nutritional product, in accordance with this invention, utilizes L-asparagine monohydrochloride and L-glutamine in place of L-aspartic acid and L-glutamic acid, respectively. In addition, the source of fat comprises soy, fractionated coconut oil (medium chain triglycerides), high oleic safflower oil and esterified glycerol emulsifiers.Type: GrantFiled: June 1, 1999Date of Patent: June 12, 2001Assignee: Abbott LaboratoriesInventors: Phyllis J. B. Acosta, Marlene W. Borschel, Patricia A. Reynolds, Christopher T. Cordle, Geralyn O. Duska-McEwen
-
Patent number: 5922766Abstract: This invention relates to a palatable elemental nutritional formula that is nutritionally complete for humans with specialized dietary needs. The nutritional of the present invention uses specific free amino acids to provide the source of amino nitrogen (protein equivalents) and a special blend of fats that provides 38 to 50% of the total Calories in a pleasant tasting formula. The nutritionally complete formula of this invention is useful for children having multiple protein allergies, short gut syndrome, sick gut, diarrhea and the like. More specifically, the nutritional product, in accordance with this invention, utilizes L-asparagine monohydrochloride and L-glutamine in place of L-aspartic acid and L-glutamic acid, respectively. In addition, the source of fat comprises soy, fractionated coconut oil (medium chain triglycerides), high oleic safflower oil and esterified glycerol emulsifiers.Type: GrantFiled: July 2, 1997Date of Patent: July 13, 1999Inventors: Phyllis J. B. Acosta, Marlene W. Borschel, Patricia A. Reynolds, Christopher T. Cordle, Geralyn O. Duska-McEwen
-
Patent number: 5837312Abstract: A method for debittering and reducing the allergenic reactivity of protein hydrolysates is disclosed, which method includes the providing of an aqueous solution of a protein hydrolysate, feeding the solution into a bed of siloxane, and collecting a first portion of the solution exiting from the bed. The first portion contains either a non-bitter or bitter fraction. A second portion of the solution exiting from the bed can be collected which contains the opposite tasting fraction of the hydrolysate. Preferably the siloxane is selected from the group comprising octa-siloxane and octadecyl-siloxane. Preferably the hydrolysate has a molecular weight of less than 10,000, and is derived from the group of hydrolysates comprising casein, whey and soy. Additionally, the bed preferably is of a depth of between 2 to 4 times the bed diameter. A more hypoallergenic protein hydrolysate product produced in accordance with the method of the invention is also disclosed.Type: GrantFiled: September 20, 1996Date of Patent: November 17, 1998Assignee: Abbott LaboratoriesInventors: Christopher T. Cordle, Shih-Bin Lin, Lynn P. Nelles, Ronald L. Thomas
-
Patent number: 5260057Abstract: This invention describes a product obtained from the isolation and concentration of specific immunoglobulins (antibodies) derived from the mammary secretions of cows immunized with Helicobacter pylori. The product is useful in preparing formulations for the treatment and/or prevention of gastric diseases.Type: GrantFiled: December 31, 1992Date of Patent: November 9, 1993Assignee: Abbott LaboratoriesInventors: Christopher T. Cordle, Joseph P. Schaller
-
Patent number: 5258178Abstract: This invention describes a product obtained from the isolation and concentration of specific immunoglobulins (antibodies) derived from the mammary secretions of cows immunized with Helicobacter pylori. The product is useful in preparing formulations for the treatment and/or prevention of gastric diseases.Type: GrantFiled: August 7, 1992Date of Patent: November 2, 1993Assignee: Abbott LaboratoriesInventors: Christopher T. Cordle, Joseph P. Schaller
-
Patent number: 4897465Abstract: Disclosed are ultrafiltration processes for the enrichment and concentration of selected proteins from protein conaining fluids. Illustratively, IgG is concentrated from whey by means of multiple ultrafiltration "passes", using a metallic oxide ultrafiltration membrane, which are characterized by differing pH's.Type: GrantFiled: October 12, 1988Date of Patent: January 30, 1990Assignee: Abbott LaboratoriesInventors: Christopher T. Cordle, Larry G. Criswell, Ronald L. Thomas